Since liver is a target for growth hormone action, binding of 125I-labeled human growth hormone to enzymatically isolated rat hepatocytes was studied. Specific binding was shown with hepatocytes from both male and female animals. There was a single class of receptors for human growth hormone on cells from males (affinity constant, Ka = 1.16 X 109 liters/mole; sites per cell, q = 6200). In males, bovine growth hormone was almost as potent as human growth hormone in displacing bound 123I-labeled human growth hormone, while ovine prolactin was about 1000 times less potent.
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Cells from female rats bound more 25I-labeled human growth hormone than cells from males. The cells from females contained at least two classes of receptors for human growth hormone. The receptor of highest affinity had the same affinity for human growth hormone as the single receptor found in males (Ka = 0.96 X 109 liters mole). However, there were three to four times as many of these receptors per cell in females (q = 21,000). In females, bovine growth hormone and ovine prolactin were both about 20 times less potent than human growth hormone. Treatment of male rats with estrone produced cells that show the same binding characteristics as females.
These results indicate that human growth hormone binds to a somatogenic receptor in hepatocytes from male rats. In females and estrogen-treated males, the receptors that bind human growth hormone recognize lactogenic as well as somatogenic properties. This suggests that the lactogenic and growth-promoting effects of human growth hormone in the rat are mediated by different receptors.
The effects of growth hormone on skeletal growth appear to be mediated by somatomedins (1) . When 125I-labeled human growth hormone (hGH) is injected in rats in vivo, much of the activity is localized in the liver (2) . Somatomedin is produced when rat liver is perfused with growth hormone (3, 4) . These findings suggest that liver is a target organ for growth hormone. The first step in the action of polypeptide hormones is binding to specific receptors on the surface of target cells. Recently, binding of 125I-labeled hGH to cell membranes prepared from livers of rabbits, rats, and other species has been reported (5) (6) (7) (8) . Binding to rat liver membranes could only be demonstrated using female or estrogen-treated male animals. In these membrane preparations, ovine prolactin (oPRL) was identical to hGH in displacing bound labeled hGH (8) . It was therefore concluded that hGH binds to a lactogenic receptor in rat liver. The present study was carried out to examine the binding characteristics of hGH to rat liver using enzymatically isolated rat hepatocytes. Differences in males and females and effects of estrone treatment in male animals on binding of 125I-labeled hGH were studied, leading to models for growth hormone receptors in the rat liver.
MATERIALS AND METHODS Animals. Sprague-Dawley rats, obtained from Charles River, Inc. and weighing 150-250 g, were starved overnight prior to preparation of isolated hepatocytes. Estrone-treated male rats were given 50 .ug of estrone diluted in corn oil (8) by subcutaneous injection for 10 days.
Hepatocytes. Suspensions of isolated hepatocytes were prepared by enzymatic digestion of perfused liver with collagenase (Worthington, crude bacterial collagenase, Type I) using the method of Berry and Friend (9) modified by Krebs et Fig. 2 , the initial binding was similar in females and estrone-treated males, but higher than in males. There was significant displacement of bound '25I-labeled hGH by 2.9 ng/ml (1.47 X 10-10 M) of unlabeled hGH. Porcine insulin, porcine glucagon, and bovine parathormone, at concentrations up to 1.7 jig/ml, failed to displace bound labeled hGH. ng/ml). In estrone-treated males, the potencies of the three hormones were similar to those found in females. Scatchard plot analysis Shown in Fig. 6 are Scatchard plots (14) for hGH binding to hepatocytes from a male, a female, and an estrone-treated male rat. The plot is linear in the male, indicating the presence of a single class of receptors. In the females and estrone-treated males, curvature of the plots indicates the presence of two or more classes of receptors.
The Scatchard plots from each of the experiments in six males, eight females, and four estrone-teated males were calculated and analyzed using the computer program previously described (13 (19) . If the former interpretation is correct, the higher affinity site has the same affinity constant for hGH as the single site in males. Estimates of the number of such receptors per cell are higher than for males. The number and affinity of the secondary class of receptors for hGH cannot be estimated from the present data.
With hepatocytes from female rats, bGH and oPRL are approximately equipotent in displacing bound 125I-labeled hGH. In contrast to results using male cells, the ED50 of bGH is 20-fold greater than that of hGH and the displacement curves are not parallel. Ovine prolactin is much more potent in displacing 125I-labeled hGH from female than from male cells. However, the ED50 of ovine prolactin is also 20-fold greater than that of hGH and the displacement curves are not parallel. Since physiologic concentrations of either bGH or oPRL give partial displacement of 125I-labeled hGH, the binding of hGH in females appears to combine both somatogenic and lactogenic properties. The postulated second site for hGH binding to hepatocytes from female and estrogen-treated male rats may be identical to the "lactogenic" receptor reported by Posner et al. (8) for rat liver membranes. However, liver membranes from untreated male rats did not bind '25I-labeled hGH and there was no evidence for a separate site with somatogenic specificity in liver membranes from female rats. The demonstration of "somatogenic" binding sites in rat hepatocytes is consistent with the hypothesis that the liver is a target organ for the growth promoting properties of growth hormones and suggests that the lactogenic and somatogenic effects of hGH in rats are mediated by different receptors.
